...
首页> 外文期刊>Folia histochemica et cytobiologica >11beta-hydroxysteroid dehydrogenase type 2 expression in the newly formed Leydig cells after ethane dimethanesulphonate treatment of adult rats.
【24h】

11beta-hydroxysteroid dehydrogenase type 2 expression in the newly formed Leydig cells after ethane dimethanesulphonate treatment of adult rats.

机译:乙烷二甲磺酸酯处理成年大鼠后,新形成的Leydig细胞中11β-羟类固醇脱氢酶2型的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD) catalyzes the reversible conversion of physiologically active corticosterone to the biologically inert 11beta-dehydrocorticosterone in rat testis and protect the Leydig cells (LCs) against the suppressive effect of glucocorticoids. The developmental pathway of the adult LCs population is accompanied with an increase in the 11beta-HDS activity. Thus, 11beta-HDS together with its role in controlling the toxicological effect of glucocorticoids on LCs can be used as a marker for their functional maturity. Ethane 1,2-dimethanesulphonate (EDS) treatment of adult rats become unique appropriate model, which enable to answer many questions related to the differentiation of adult LCs in the prepubertal rat testis. The aim of the present study was to investigate the specific changes in the 11beta-HDS type 2 immunoreactivity in tandem with the expression of androgen receptor (AR) during renewal of LCs population after EDS treatment. In the present study, we observed the first appearance of immunostaining for 11beta-HSD2 in new LCs population on day 14 after EDS administration when the progenitor LCs were detected. Our immunohistochemical analysis revealed progressive increases in the 11beta-HSD2 reaction intensity on 21 days after EDS treatment and reached a maximum on day 35. AR immunoexpression was found in new LCs on day 14 and 21 after EDS injection with an increasing curve of intensity. The most prominent AR immunostaining in new population LCs was evident by 35 days after EDS and that coincided with the increased number of LCs and restoration of adult LCs population. Our results demonstrated similar pattern of immunoreactivity for 11beta-HSD2 and AR in new LCs population after EDS treatment and suggested that the changes in 11beta-HSD2 expression can be used for evaluation of adult LCs differentiation in rat testis.
机译:酶11β-羟类固醇脱氢酶(11beta-HSD)催化大鼠睾丸中生理活性皮质酮向生物惰性11beta-脱氢皮质酮的可逆转化,并保护Leydig细胞(LC)免受糖皮质激素的抑制作用。成人LC人群的发育途径伴随着11beta-HDS活性的增加。因此,11beta-HDS及其在控制糖皮质激素对LC的毒理作用中的作用可以用作其功能成熟的标志。乙烷1,2-二甲磺酸酯(EDS)处理成年大鼠成为独特的合适模型,它能够回答许多与青春期前睾丸中成年LC分化有关的问题。本研究的目的是研究EDS治疗后LC人群更新期间11beta-HDS 2型免疫反应性与雄激素受体(AR)的表达的特异性变化。在本研究中,我们观察到在检测到祖细胞LC的EDS后第14天,在新LC群体中首次出现了11beta-HSD2的免疫染色。我们的免疫组织化学分析显示,EDS治疗后21天11beta-HSD2反应强度逐渐增加,并在35天达到最大。在EDS注射后第14天和21天,新LC中发现AR免疫表达,强度曲线呈递增趋势。在EDS后35天,新人群LC中最显着的AR免疫染色是明显的,这与LC数量的增加和成年LC人群的恢复相吻合。我们的结果表明,经过EDS处理后,新LC群体中11beta-HSD2和AR的免疫反应性相似,并表明11beta-HSD2表达的变化可用于评估大鼠睾丸中成年LC的分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号